La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Kingworld Medicines Group Gestion
Gestion contrôle des critères 3/4
We currently do not have sufficient information about the CEO.
Informations clés
Li Sheng Zhao
Directeur général
CN¥1.5m
Rémunération totale
Pourcentage du salaire du PDG | 98.5% |
Durée du mandat du directeur général | 15.9yrs |
Propriété du PDG | 54.1% |
Durée moyenne d'occupation des postes de direction | pas de données |
Durée moyenne du mandat des membres du conseil d'administration | 14.4yrs |
Mises à jour récentes de la gestion
Recent updates
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338
May 31Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely
May 22Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings
Apr 29Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338
Apr 23A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Mar 22The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising
Nov 30Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement
Aug 17Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247
May 30The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing
May 11Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247
Apr 03Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture
Feb 07A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Oct 07Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business
Jul 05Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024
Apr 27We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)
Aug 17Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)
Mar 29Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares
Mar 08Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?
Feb 15Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)
Jan 25Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?
Dec 18We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation
Nov 22Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Dec 31 2023 | CN¥1m | CN¥1m | CN¥38m |
Sep 30 2023 | n/a | n/a | CN¥37m |
Jun 30 2023 | n/a | n/a | CN¥36m |
Mar 31 2023 | n/a | n/a | CN¥29m |
Dec 31 2022 | CN¥1m | CN¥1m | CN¥23m |
Sep 30 2022 | n/a | n/a | CN¥29m |
Jun 30 2022 | n/a | n/a | CN¥35m |
Mar 31 2022 | n/a | n/a | CN¥33m |
Dec 31 2021 | CN¥1m | CN¥1m | CN¥30m |
Sep 30 2021 | n/a | n/a | CN¥26m |
Jun 30 2021 | n/a | n/a | CN¥21m |
Mar 31 2021 | n/a | n/a | CN¥17m |
Dec 31 2020 | CN¥1m | CN¥1m | CN¥12m |
Sep 30 2020 | n/a | n/a | CN¥16m |
Jun 30 2020 | n/a | n/a | CN¥20m |
Mar 31 2020 | n/a | n/a | CN¥32m |
Dec 31 2019 | CN¥2m | CN¥2m | CN¥43m |
Sep 30 2019 | n/a | n/a | CN¥45m |
Jun 30 2019 | n/a | n/a | CN¥46m |
Mar 31 2019 | n/a | n/a | CN¥44m |
Dec 31 2018 | CN¥1m | CN¥1m | CN¥41m |
Sep 30 2018 | n/a | n/a | CN¥49m |
Jun 30 2018 | n/a | n/a | CN¥56m |
Mar 31 2018 | n/a | n/a | CN¥54m |
Dec 31 2017 | CN¥2m | CN¥1m | CN¥51m |
Rémunération vs marché: Li Sheng's total compensation ($USD203.44K) is about average for companies of similar size in the Hong Kong market ($USD235.43K).
Rémunération et revenus: Li Sheng's compensation has been consistent with company performance over the past year.
PDG
Li Sheng Zhao (66 yo)
15.9yrs
Titularisation
CN¥1,452,000
Compensation
Mr. Li Sheng Zhao is a Co-founder of Kingworld Medicines Group Limited and serves as its Chief Executive Officer. Mr. Zhao is responsible for Kingworld Medicines Group's overall strategic planning and busi...
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Co-Founder | 15.9yrs | CN¥1.45m | 54.1% CN¥ 163.5m | |
Co-Founder & Executive Director | 15.9yrs | CN¥1.32m | 15.24% CN¥ 46.1m | |
Executive Director | 15yrs | CN¥483.00k | 0.45% CN¥ 1.4m | |
Independent Non-Executive Director | 13.8yrs | CN¥285.00k | 0.036% CN¥ 108.1k | |
Independent Non-Executive Director | 13.8yrs | CN¥285.00k | pas de données | |
Independent Non-Executive Director | 11yrs | CN¥285.00k | 0.042% CN¥ 126.5k |
14.4yrs
Durée moyenne de l'emploi
60yo
Âge moyen
Conseil d'administration expérimenté: 1110's board of directors are seasoned and experienced ( 14.4 years average tenure).